FIELD: medicine, oncology, biochemistry, pharmacy. SUBSTANCE: invention relates to medicinal preparations, in particular, retroviral vectors transducing cytochrome P-450. Invention involves pharmaceutical composition for carrying out an anti-tumor therapy and representing capsule, encapsulating cell comprising gene that expresses cytochrome P-450. Capsule comprises porous membrane that is permeable for prodrug molecules that is activated with cytochrome P-450 and converted to an active metabolite. The advantage of invention is the development of new replicatively defective retroviral vectors carrying gene encoding cytochrome P-450. EFFECT: valuable properties of vectors. 7 cl, 5 ex
Authors
Dates
2004-02-20—Published
1997-03-27—Filed